Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference

  Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference

RBC Capital Markets Global Healthcare Conference 2013

Business Wire

JERUSALEM -- February 25, 2013

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio
webcast at the 2013 RBC Capital Markets Global Healthcare Conference. Jon
Congleton, SVP, Global Medicines Group, will present on Wednesday, February
27, 2013.

What:    Teva Presentation at the 2013 RBC Capital Markets Global Healthcare
         Conference
          
Who:     Jon Congleton, SVP, Global Medicines Group
          
When:    Wednesday, February 27 2013 at 1:30 PM (EST)
          
Where:   www.tevapharm.com or
         http://www.veracast.com/webcasts/rbc/healthcare2013/38211345.cfm
          
How:     Live over the Internet – log on to the Web at the address above and
         register for the
         event (approximately 10 minutes before). An archive of the webcast
         will be available
         on Teva’s website.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic drugs as
well as innovative and specialty pharmaceuticals and active pharmaceutical
ingredients. Headquartered in Israel, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,000 molecules and a
direct presence in about 60 countries. Teva's branded businesses focus on CNS,
oncology, pain, respiratory and women's health therapeutic areas as well as
biologics. Teva currently employs approximately 46,000 people around the world
and reached $20.3 billion in net revenues in 2012.

Contact:

Teva Pharmaceutical Industries Ltd.
IR:
Kevin C. Mannix
United States
215-591-8912
or
Kristen Frank
United States
215-591-8908
or
Tomer Amitai
Israel
972 (3) 926-7656
or
PR:
Hadar Vismunski-Weinberg
Israel
972 (3) 926-7687
or
Denise Bradley
United States
215-591-8974